The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections

The STI diagnostic landscape of FDA cleared tests for use at point-of-care (POC), as well as those emergency use authorized for COVID-19 are reviewed; some of these COVID-19 diagnostics may have platform potential as STI diagnostics. Finally, process innovation is described with self-collection and...

Descripción completa

Detalles Bibliográficos
Autor principal: Manabe, Yukari C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604101/
https://www.ncbi.nlm.nih.gov/pubmed/34808115
http://dx.doi.org/10.1016/j.clinbiochem.2021.11.003
_version_ 1784601883797618688
author Manabe, Yukari C.
author_facet Manabe, Yukari C.
author_sort Manabe, Yukari C.
collection PubMed
description The STI diagnostic landscape of FDA cleared tests for use at point-of-care (POC), as well as those emergency use authorized for COVID-19 are reviewed; some of these COVID-19 diagnostics may have platform potential as STI diagnostics. Finally, process innovation is described with self-collection and hub-and-spoke mail-in to reference lab models. Movement of Clinical Laboratory Improvement Amendments (CLIA)-waived POC tests to over-the-counter formats will make tests more accessible to consumers. Together with public health messaging, these measures could accelerate STI and COVID-19 syndemic diagnostic solutions.
format Online
Article
Text
id pubmed-8604101
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-86041012021-11-22 The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections Manabe, Yukari C. Clin Biochem Article The STI diagnostic landscape of FDA cleared tests for use at point-of-care (POC), as well as those emergency use authorized for COVID-19 are reviewed; some of these COVID-19 diagnostics may have platform potential as STI diagnostics. Finally, process innovation is described with self-collection and hub-and-spoke mail-in to reference lab models. Movement of Clinical Laboratory Improvement Amendments (CLIA)-waived POC tests to over-the-counter formats will make tests more accessible to consumers. Together with public health messaging, these measures could accelerate STI and COVID-19 syndemic diagnostic solutions. The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2023-07 2021-11-19 /pmc/articles/PMC8604101/ /pubmed/34808115 http://dx.doi.org/10.1016/j.clinbiochem.2021.11.003 Text en © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Manabe, Yukari C.
The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
title The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
title_full The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
title_fullStr The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
title_full_unstemmed The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
title_short The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
title_sort impact of covid-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604101/
https://www.ncbi.nlm.nih.gov/pubmed/34808115
http://dx.doi.org/10.1016/j.clinbiochem.2021.11.003
work_keys_str_mv AT manabeyukaric theimpactofcovid19pandemicontechnologicandprocessinnovationinpointofcarediagnosticsforsexuallytransmittedinfections
AT manabeyukaric impactofcovid19pandemicontechnologicandprocessinnovationinpointofcarediagnosticsforsexuallytransmittedinfections

Ejemplares similares